Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $88.2B |
| FY2017, ended Dec 31, 2017 | $115B |
| FY2018, ended Dec 31, 2018 | $96.3B |
| FY2019, ended Dec 31, 2019 | $126B |
| FY2020, ended Dec 31, 2020 | $148B |
| FY2021, ended Dec 31, 2021 | $143B |
| FY2022, ended Dec 31, 2022 | $143B |
| FY2023, ended Dec 31, 2023 | $137B |
| FY2024, ended Dec 31, 2024 | $147B |
| FY2025, ended Dec 31, 2025 | $124B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $66.9B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $39.3B |
| FY2017, ended Dec 31, 2017 | $40.5B |
| FY2018, ended Dec 31, 2018 | $41.8B |
| FY2019, ended Dec 31, 2019 | $36.7B |
| FY2020, ended Dec 31, 2020 | $32.6B |
| FY2021, ended Dec 31, 2021 | $34.4B |
| FY2022, ended Dec 31, 2022 | $35.5B |
| FY2023, ended Dec 31, 2023 | $33.0B |
| FY2024, ended Dec 31, 2024 | $34.7B |
| FY2025, ended Dec 31, 2025 | $37.4B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $37.7B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $4.81B | $4.40B |
| FY2017, ended Dec 31, 2017 | $1.54B | $4.93B |
| FY2018, ended Dec 31, 2018 | $6.76B | $5.61B |
| FY2019, ended Dec 31, 2019 | $6.14B | $6.06B |
| FY2020, ended Dec 31, 2020 | $4.78B | $5.30B |
| FY2021, ended Dec 31, 2021 | $5.54B | $5.14B |
| FY2022, ended Dec 31, 2022 | $4.97B | $4.51B |
| FY2023, ended Dec 31, 2023 | $5.66B | $4.60B |
| FY2024, ended Dec 31, 2024 | $5.71B | $5.23B |
| FY2025, ended Dec 31, 2025 | $4.73B | $5.42B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $7.05B | $967M |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.84B |
| FY2017, ended Dec 31, 2017 | $7.06B |
| FY2018, ended Dec 31, 2018 | $9.29B |
| FY2019, ended Dec 31, 2019 | $9.07B |
| FY2020, ended Dec 31, 2020 | $14.3B |
| FY2021, ended Dec 31, 2021 | $11.0B |
| FY2022, ended Dec 31, 2022 | $9.63B |
| FY2023, ended Dec 31, 2023 | $7.92B |
| FY2024, ended Dec 31, 2024 | $9.91B |
| FY2025, ended Dec 31, 2025 | $12.3B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $5.69B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $15.8B |
| FY2017, ended Dec 31, 2017 | $17.9B |
| FY2018, ended Dec 31, 2018 | $16.2B |
| FY2019, ended Dec 31, 2019 | $16.0B |
| FY2020, ended Dec 31, 2020 | $22.4B |
| FY2021, ended Dec 31, 2021 | $19.6B |
| FY2022, ended Dec 31, 2022 | $19.6B |
| FY2023, ended Dec 31, 2023 | $20.4B |
| FY2024, ended Dec 31, 2024 | $31.1B |
| FY2025, ended Dec 31, 2025 | $34.6B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $16.6B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 58.3% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 761M |
| FY2017, ended Dec 31, 2017 | 752M |
| FY2018, ended Dec 31, 2018 | 729M |
| FY2019, ended Dec 31, 2019 | 713M |
| FY2020, ended Dec 31, 2020 | 696M |
| FY2021, ended Dec 31, 2021 | 686M |
| FY2022, ended Dec 31, 2022 | 668M |
| FY2023, ended Dec 31, 2023 | 652M |
| FY2024, ended Dec 31, 2024 | 650M |
| FY2025, ended Dec 31, 2025 | 636M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 317M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.08B | $184M |
| FY2017, ended Dec 31, 2017 | $2.89B | $176M |
| FY2018, ended Dec 31, 2018 | $4.00B | $175M |
| FY2019, ended Dec 31, 2019 | $4.40B | $153M |
| FY2020, ended Dec 31, 2020 | $3.71B | $168M |
| FY2021, ended Dec 31, 2021 | $3.38B | $217M |
| FY2022, ended Dec 31, 2022 | $4.20B | $188M |
| FY2023, ended Dec 31, 2023 | $3.71B | $197M |
| FY2024, ended Dec 31, 2024 | $1.66B | $189M |
| FY2025, ended Dec 31, 2025 | $3.80B | $196M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.10B | $263M |
Valuation
At current price- Market Cap
- $69.4B
- P/E
- 9.8×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.8×
- Price / Book
- 3.1×
- EV / EBITDA
- 8.1×
Growth
Trailing 12 months- Revenue (TTM)
- $37.7B
- Revenue Growth YoY
- 79.6%
- Revenue CAGR 3Y
- 1.8%
- Revenue CAGR 5Y
- 2.8%
- EPS Growth YoY
- −13.1%
- Net Income Growth YoY
- 15.1%
Profitability
Trailing 12 months- Gross Margin
- 37.2%
- Operating Margin
- 22.7%
- Net Margin
- 18.7%
- FCF Margin
- 2.6%
- Return on Equity
- 36.0%
Earnings
Trailing 12 months- Net Income
- $7.05B
- EPS (diluted)
- $14.78
- EBITDA
- $9.93B
- Operating Income
- $8.55B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $5.69B
- Total Debt
- $16.6B
- Net Debt
- $10.9B
- Total Assets
- $53.1B
- Total Liabilities
- $30.4B
- Shareholders' Equity
- $22.4B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $1.95B
- Capital Expenditure
- $980M
- Free Cash Flow
- $967M
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $4.44
- Beta (5Y)
- 0.83
Every ratio is calculated from the company’s reported figures.